glp 1 and ketosis Bozmd Unlocking the Potential of GLP-1 Medications Could a keto diet replace
Description
GLP-1-GIP co-agonist tirzepatide was approved by the US Food and Drug Administration in 2022 for the treatment of T2DM (Nogueiras et al., 2023)
Khunti K, Davies MJ
The patient may experience severe headaches, dizziness, and diarrhea
Do I need a different syringe for tirzepatide vs semaglutide
In the upcoming sections, we'll explore all questions related to "What are GLP-1 medications?" including their benefits and risks
Food audit (35 days): log portions
